The role of cagA Helicobacter pylori strains in gastro-oesophageal reflux disease

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 7, 2004, Pages 643-647

  Pereira Lima, Júlio C ^a,b   Marques, Daniela L ^a   Pereira Lima, Lucas F ^a   Hornos, Alexander P ^a   Rota, Claudia ^a  

^a Santa Casa   (Brazil)

^b NONE   (Brazil)

Author keywords

cagA; Gastro oesophageal reflux disease; Helicobacter pylori

Indexed keywords

CAGA PROTEIN; UREASE;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CONTROLLED STUDY; DUODENITIS; DYSPEPSIA; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; STOMACH BIOPSY;

ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; ESOPHAGITIS, PEPTIC; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; VIRULENCE;

EID: 3142557835     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000108340.41221.9e     Document Type: Article

References (35)

1. Vaezi MF, Falk GW, Peek RM, Vicari JJ, Goldblum JR, Perez-Perez GI, et al. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus. Am J Gastroenterol 2000; 95:2206-2211.
2. Gisbert JP, Pajaras JM, Losa C. Helicobacter pylori and gastroesophageal reflux disease: friends or foes? Hepato-Gastroenterology 1999; 46:1023-1029.
3. Pereira-Lima JC, Scholl JG, Pinheiro JB, Pereira-Lima L, Riemann JF. Helicobacter pylori-associated gastritis: does it play a role in functional dyspepsia? Z Gastroenterol 1995; 33:521-525.
4. Pereira-Lima JC, Blaya C, Rynkowski C, Althaus W, Frey BN, Prati C. Prevalência da doença do refluxo gastro-esofȧgico: estudo populacional em Porto Alegre. Gastroenterol Endosc Dig 2000; 19:73-78.
5. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 342:1175-1186.
6. Varanasi RV, Fantry GT, Wilson KT. Decreased prevalence of H. pylori infection in gastroesophageal reflux disease. Helicobacter 1998; 3: 188-194.
7. Wu JC, Sung JJ, Ng EK, Go MY, Chan WB, Chan FK, et al. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: a study from the East. Am J Gastroenterol 1999; 94:1790-1794.
8. Pieramico A, Zanetti MV. Role of H. pylori infection in gastroesophageal reflux disease [Abstract]. Gut 1997; 4:24.
9. Fallone CA, Barkun AN, Gottke MU, Best LM, Loo VG, van Zanten SV, et al. Association of Helicobacter pylori genotype with gastroesophageal reflux disease and upper gastrointestinal diseases. Am J Gastroenterol 2000; 95:659-669.
10. Weston AP, Badr AS, Topalovski M, Cherian R, Dixon A, Hassanein RS. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol 2000; 95:387-394.
11. Tapes B, Kavcic B, Gubina M, Krizman I. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication. HepatoGastroenterology 1999; 46:1746-1750.
12. Rota CA, Pereira-Lima JC, Blaya C, Nardi NB. Consensus and variable region PCR analysis of Helicobacter pylori 3′ region of cagA gene in isolates from individuals with or without peptic ulcer. J Clin Microbiol 2001; 39:606-612.
13. Queiroz DM, Rocha GA, Oliveira CA, Rocha AM, Santos A, Cabral MM, Nogueira AM. Role of corpus gastritis and cagA-positive Helicobacter pylori infection in reflux esophagitis. J Clin Microbiol 2002; 40: 2849-2853.
14. Arents NL, van Zwet AA, Thijs JC, Kooistra-Smid AM, van Slochteren KR, Degener JE, et al. The importance of vacA, cagA, and iceA genotypes of Helicobacter pylori infection in peptic ulcer disease and gastroesophageal reflux disease. Am J Gastroenterol 2001; 96:2603-2608.
15. Galmiche JP, Scarpignato C. Modern diagnosis of gastroesophageal reflux disease (GERD). Hepato-Gastroenterology 1998; 45:1308-1315.
16. Price AB. The Sydney system: histological division. J Gastroenterol Hepatol 1991; 6:209-222.
17. Furuta T, Kaneko E, Suzuki M, Arai H, Futami H. Quantitative study of Helicobacter pylori in gastric mucus by competitive PCR using synthetic DNA fragments. J Clin Microbiol 1996; 34:2421-2425.
18. Clayton CL, Kleanthous H, Coates PJ, Morgan DD, Tabaqchali S. Sensitive detection of H. pylori by using polymerase chain reaction. J Clin Microbiol 1992; 30:192-200.
19. Sambrook, J, Fritisch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989.
20. Yamaoka Y, Kodama T, Kashima K, Graham DY, Sepulveda AR. Variants of the 3′ region of the cag A gene in Helicobacter pylori isolates from patients with different H pylori associated diseases. J Clin Microbiol 1998; 36:2258-2263.
21. Bukanov NO, Berg DE. Ordered cosmid library and high-resolution physical genetic map of H. pylori strain NETC 11638. Mol Microbiol 1994; 11:509-523.
22. Graham DY. The only good Helicobacter pylori is a dead Helicobacter pylori. Lancet 1997; 350:70-71.
23. Warburton-Timms VJ, Charlett A, Valori RM, Uff JS, Shepherd NA, Barr H, McNulty CAM. The significance of cagA+ Helicobacter pylori in reflux oesophagitis. Gut 2001; 49:341-346.
24. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux oesophagitis. Gastroenterology 1997; 112:1442-1447.
25. O'Connor HJ, McGee C, Ghabash NM, Cunnane K. Prevalence of esophagitis in H. pylori-positive peptic ulcer disease and the impact of eradication therapy. Hepato-Gastroenterology 2001; 48:1064-1068.
26. Besisik F, Sürücü F, Mungan Z, Dinçer D, Kapran Y, Kaymakoglu S, Çevikbas U. Helicobacter pylori eradication lowers esophageal sphincter pressures in functional dyspepsia patients. Hepato-Gastroenterology 2001; 48:1772-1775.
27. Laine L, Sugg J. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies. Am J Gastroenterol 2002; 97:2992-2997.
28. Moayyedi P, Bardhan C, Young L, Dixon MF, Brown L, Axon AT. Helicobacter pylori eradication does not exacerbate reflux symptoms gastroesophageal reflux disease. Gastroenterology 2001; 121: 1120-1126.
29. Schwizer W, Thumshirn M, Dent J, Guldenschuh I, Menne D, Cathomas G, Fried M. Helicobacter pylori and symptomatic relapse of gastroesophageal reflux disease: a randomized controlled trial. Lancet 2001; 357:1738-1742.
30. Loffeld RJLF, Ten Tije BJ, Arends JW. Prevalence and significance of Helicobacter pylori in patients with Barrett's esophagus. Am J Gastroenterol 1992; 87:1598-1600.
31. Henihan RDJ, Stuart RC, Nolan N, Path FRC, Gorey TF, Hennessy TPJ, et al. Barrett's esophagus and the presence of Helicobacter pylori. Am J Gastroenterol 1998; 93:542-546.
32. Quddus MR, Sulaiman RA, Henley JD, Palumbo TC, Gnepp DR. Lack of association of Helicobacter pylori infection and adenocarcinoma arising in Barrett's esophagus [Abstract]. Mod Pathol 1996; 9:1.
33. Schenk BE, Kuipers EJ, Klinkenberg-knol EC, Eskes SA, Meuwissen SGM. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. Am J Gastroenterol 1999; 94: 884-887.
34. Falk GW, Reflux disease and Barrett's esophagus. Endoscopy 1999; 31:9-16.
35. Falk GW. Gastroesophageal reflux and Barrett's esophagus. Endoscopy 2001; 33:109-118.